Paradigm Biopharma (@paradigmbio) 's Twitter Profile
Paradigm Biopharma

@paradigmbio

ID: 737458048784945152

linkhttp://www.paradigmbiopharma.com calendar_today31-05-2016 01:37:54

441 Tweet

604 Followers

245 Following

Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Today Paradigm received a $7.36 million tax incentive refund. Read more here: cdn-api.markitdigital.com/apiman-gateway…

Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Arthritis Australia's Senate Inquiry appearance in Feb, spotlighted challenges faced by arthritis patients amid rising costs. CEO Jonathan Smithers stressed staggering out-of-pocket expenses, urging for change and new treatments. Read more: mailchi.mp/arthritisaustr… $PAR

Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Today, we celebrate the achievements of women worldwide, including the incredible contributions of the women at Paradigm. Your dedication is helping to shape the future of care for those suffering from osteoarthritis. Thank you for your invaluable impact on the organisation.

Stockhead (@stockheadau) 's Twitter Profile Photo

#ASX #biotech companies are gunning for US #FDA approval as that not only validates the safety and efficacy of a new drug, but also offers commercial opportunities. bit.ly/4blDSrJ

Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Managing Director, Paul Rennie, will be presenting at the upcoming 18th Bioshares Biotech Summit on Friday 12 July, in Fremantle, Western Australia. $PAR #KneeOA #osteoarthritis #pentosan #PPS

Managing Director, Paul Rennie, will be presenting at the upcoming 18th Bioshares Biotech Summit on Friday 12 July, in Fremantle, Western Australia.

$PAR #KneeOA #osteoarthritis #pentosan #PPS
Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Founder and MD, Paul Rennie, presented Paradigm's clinical progress and exciting data to the Bioshares Biotech Summit in Fremantle last week. We would like to thank Mark Pachacz and the wider Bioshares team for the opportunity to present and an outstanding conference. $PAR #ASX

Founder and MD, Paul Rennie, presented Paradigm's clinical progress and exciting data to the Bioshares Biotech Summit in Fremantle last week. We would like to thank Mark Pachacz and the wider Bioshares team for the opportunity to present and an outstanding conference.

$PAR #ASX
Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Paradigm's 2024 Annual Report has been released. Key Highlights: - iPPS shows 12-month efficacy - Structural improvements seen at six months - PARA_OA_002 Stage 1 completed Read the full report: cdn-api.markitdigital.com/apiman-gateway…

Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Paradigm clear to proceed to our pivotal phase three clinical trial in knee osteoarthritis. This is a significant milestone for the company. The team now shifts their focus to the start-up activities to initiate patient enrolment. Read more: cdn-api.markitdigital.com/apiman-gateway…

Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Last week, Paradigm presented at the Ignite Investment Summit in Hong Kong. We had incredible engagement from leading family offices across Asia. The strong interest in our phase 3 OA program reaffirms Paradigm as a standout late-stage biotech opportunity. #IgniteConference

Last week, Paradigm presented at the Ignite Investment Summit in Hong Kong.

We had incredible engagement from leading family offices across Asia. The strong interest in our phase 3 OA program reaffirms Paradigm as a standout late-stage biotech opportunity.

#IgniteConference
Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

We're hiring! Paradigm is looking for a Clinical Operations Lead (Hybrid) to manage global trials for our ASX-listed biotech. Apply now 👉 seek.com.au/job/83522919 #BiotechJobs #ClinicalResearch #Hiring #ASX $PAR #PharmaCareers #RemoteWork

Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

We’ve secured centralised US ethics approval for our Phase 3 trial of iPPS in knee osteoarthritis. A significant step in expanding our clinical program and advancing a first-in-class treatment for millions. See Paul Rennie’s comments & full ASX release:cdn-api.markitdigital.com/apiman-gateway…

HotCopper (@hotcopper) 's Twitter Profile Photo

This stock could have something close to a cure for #osteoarthritis. Don’t let it hide under your nose Paradigm Biopharmaceuticals (#ASX: $PAR) Managing Director Paul Rennie spoke with The Market Online to discuss further > Find out more: hotcopper.com.au/news/asx-news/… Paradigm Biopharma

This stock could have something close to a cure for #osteoarthritis. Don’t let it hide under your nose

Paradigm Biopharmaceuticals (#ASX: $PAR) Managing Director Paul Rennie spoke with The Market Online to discuss further >

Find out more: hotcopper.com.au/news/asx-news/…

<a href="/ParadigmBio/">Paradigm Biopharma</a>
Paradigm Biopharma (@paradigmbio) 's Twitter Profile Photo

Today, Paradigm Biopharmaceuticals announced the acquisition of Proteobioactives, securing global rights to a patented oral combination of PPS and a COX-2 inhibitor, targeting early-stage osteoarthritis in both humans and animals. Read more here: cdn-api.markitdigital.com/apiman-gateway…